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ABSTRACT 
Background: Armed conflicts significantly contribute to the global burden of injury and 
death. Armed conflicts shocks health systems, deprive its resources and reduce its function, 
as well as limits access to civilian hospital care. In such resource-limited settings, the 
evidence on how to optimally manage the injuries sustained by civilians remains scarce. 
Objectives: To generate knowledge on how wound infection affects outcomes for civilian 
patients treated for conflict-related injuries, to explore the challenges associated with the 
treatment of such patients, and to evaluate the safety, effectiveness, and cost-effectiveness of 
negative pressure wound therapy (NPWT) for conflict-related extremity wounds. 
Methods: All patients were wounded in armed conflicts in Syria and Iraq. The studies were 
performed at two civilian hospitals in Jordan and Iraqi Kurdistan. In a cohort study (Paper I), 
utilising routinely collected clinical data from consecutive patients surgically treated for 
conflict-related injuries, we compared patients with wound infection to those without, in 
terms of clinical outcome and resource consumption. Paper II was a qualitative study where 
treating physicians in Jordan were interviewed to explore the perceived main challenges in 
conflict wound management. Paper III was a randomised controlled trial on the safety and 
effectiveness of NPWT compared to standard treatment for conflict-related extremity 
wounds. In Paper IV we used clinical outcome data from Paper III to perform a health 
economic evaluation of NPWT in resource-limited settings.  
Main Findings: Wound infection was associated with poor clinical outcomes and excess 
resource consumption. In addition, three out of four infected wounds contained multidrug-
resistant bacteria. The main challenges in conflict wound management related to protocol 
adherence. Reasons for protocol deviations included resource scarcity, high patient loads, and 
limited compliance among patients and caregivers. Neither time to wound closure nor net 
clinical benefit was improved by NPWT compared to standard treatment for conflict-related 
extremity wounds. Treatment-related healthcare costs were higher for NPWT compared to 
standard treatment 
Conclusions: Wound infection was associated with poor clinical outcomes and an excess 
resource consumption among patients receiving surgery for conflict-related injuries. 
Physicians found protocol adherence to be the main challenge in the management of conflict-
related wounds. NPWT did not result in superior clinical outcomes compared to standard 
treatment. In addition, costs were higher, indicating that NPWT is not a cost-effective 
treatment option.  
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PREAMBLE 
I tried to avoid getting involved with research. I wanted to focus my working hours on being 
a good doctor, and on my training to become a skilled surgeon. Then, after my first mission 
with Médecins Sans Frontières (MSF), I met Johan. At a debriefing session at the Swedish 
MSF office, I was trying to make sense of my overwhelming first encounters with extreme 
poverty. Johan summarised it for me in a few clear sentences that made me think that maybe 
there was, after all, a way to make sense of the senseless. The following years we stayed in 
touch, and I found myself slowly being drawn into the world of research. 
My first attempts included a systematic review of crush injuries following earthquakes and an 
observational study assessing the primary healthcare flood preparedness in the Vietnamese 
countryside. None of which proved to be suitable areas for a doctoral thesis. Then I got an 
email from Eugene at MSF, asking if I wanted to be part of the implementation of a new 
treatment method for Syrian civilians with acute conflict-related injuries. After some thinking 
I figured that a randomised controlled trial could be a straight-forward approach. However, I 
was not sure how to go about this task. At my new position at the Department of Surgery at 
Södersjukhuset I met Jonas and we almost immediately started discussing research. His 
enthusiasm convinced me of the feasibility to conduct a randomised clinical trial in a conflict-
affected area. The combination of Johan’s sense of context and relevance, and Jonas’ tenacity 
and methodological knowledge soon proved to be a recipe for success.  
Throughout this thesis project, I have struggled with limitations and shortcomings; mostly my 
own, but also external factors out of my control. During the running of our clinical trial in 
Jordan, for example, the Syrian border was suddenly closed due to a violent border control 
attack. This left injured Syrian patients with limited access to healthcare and us with no study 
participants. After six months of trying to figure out what to do, we managed to expand the 
trial and opened an additional site in Erbil, Iraq. Not long after, Iraqi Kurdistan voted for 
independence. Baghdad officials did not appreciate this, so they closed the Erbil airport. This 
time it was not the patients but me who could not access the hospital.  
Then there is the issue of working with war surgeons, lone wolves who have seen everything, 
done everything, and were not easily impressed by my enthusiasm and ambitious research 
ideas. I never thought that getting involved with research would bring such challenges. If I 
had known, I would never have hesitated. It has truly been an interesting and rewarding 
journey. Now I have arrived. This is the result. 
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INTRODUCTION 
During the war between Sweden and Russia in the early 1800s, mortality due to wound 
complications was high. To improve the surgical management of the injured, the Swedish 
King Karl XIII founded Karolinska Institutet in 1810 as an ‘academy for the training of 
skilled army surgeons’.1 During the following two centuries, global medical research has 
evolved immensely. However, its focus has shifted away from those wounded during armed 
conflict.2 
A starting point for research is the creation of an inventory of the existing evidence and an 
assessment of the knowledge gaps. Initiatives to increase the use of the best available 
evidence in the response to armed conflict include utilising the thousands of reviews available 
in the Cochrane Database of Systematic Reviews.3 However, when the available studies that 
might be included in a review article or meta-analysis are few and have a low evidence value, 
the conclusions that can be drawn are limited. The burden of conflict-related injuries among 
civilians is increasing.4 The predominant source of information on which to base the care for 
civilians with conflict-related injuries is anecdotal military experiences.5,6 Some of the 
treatment strategies utilised in conflict-affected areas are based on data from high-resource 
settings; however, such a transfer of evidence is not uncomplicated.7,8 Although research 
initiatives do exist, there is an urgent need for context-specific evidence to guide the 
development of best treatment strategies.2,9,10 
Research projects in conflict-affected areas are faced with three main sets of challenges:  
i) practical, related to insecurity, a damaged infrastructure, and limited resources; ii) ethical; 
and iii) methodological, as many of the available research methods are not adapted to these 
contexts.11 The overarching objective of this thesis is to explore the challenges of conducting 
research on civilians with acute conflict-related injuries, to generate new knowledge to 
inform best practices for these patients, and to assess the utility of different research methods 
in resource-limited settings.
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BACKGROUND 
Armed Conflict and Public Health 
Armed conflict is no longer understood exclusively as a war declared between countries and 
fought by national armed forces. Today the term includes asymmetric warfare, internal 
conflicts with civilian combatants, and attacks by terrorist groups. The year 2017 was one of 
the most violent since the end of the Cold War, with 49 state-based armed conflicts and 82 
non-state conflicts.12 The global number of direct fatalities caused by armed conflict and 
terrorism is increasing, reaching an estimated 129 700 in 2017.13 The number of indirect 
fatalities is unknown but armed conflicts cause societal harm far beyond that of direct and 
indirect fatalities. In 2017, the non-fatal outcomes of conflict and terrorism were estimated to 
be 2.1 million years lived with disability worldwide, which is almost equivalent to that of 
motor vehicle road injuries.4 In addition to the direct effects of armed conflict, indirect effects 
are generated by displacement, the destruction of infrastructure, and the disruption of 
healthcare delivery (Textbox 1). The direct and indirect effects of armed conflict have 
significant negative consequences for the development and can halt affected countries’ 
ambitions to reach the universally-accepted Sustainable Development Goals.14,15 
 
Textbox 1. Direct and Indirect Health Effects of Armed Conflict  
Direct effects are death and injuries directly linked to the conflict, such as those 
that result from gunshots and bombings. 
Indirect effects are secondary to factors such as displacement, forced migration, 
the destruction of infrastructure, and the disruption of healthcare delivery. 
 
Armed conflicts mainly occur in low- and middle-income countries.16 Armed conflict settings 
are characterised by instability and rapid changes in circumstances. With a sudden influx of 
critically injured patients, resources for healthcare will be limited, regardless of income level 
(Textbox 2).17 Conflict-affected settings generally have a significant burden of disease and 
injury, and a low health system resilience with insufficient infrastructure, equipment, and 
personnel.18 The extra burden generated by a conflict often leads to devastating consequences 
for the population, which are determined more by pre-conflict fragility than by the intensity 
of the conflict (Figure 1).19 In addition, warfare tactics have shifted towards targeting the 
civilian population, healthcare workers and facilities.20 The assessed proportion of civilian 
casualties of armed conflict vary, from 35% to as high as 70%.21,22  
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Figure 1. Conflict-related Deaths. Reproduced with Permission from Leaning and Guha-
Sapir,19 Copyright Massachusetts Medical Society. 
 
Textbox 2. Armed Conflict and Resource-limited Settings  
Armed conflicts can, according to the International Humanitarian Law, be 
either international (opposing two or more states) or non-international. Non-
international armed conflicts are fought ‘between governmental forces and non-
governmental armed groups, or between such groups only’.23 
Resource-limited settings have scarce material and financial means, and exist 
in either low-income countries or subareas within countries.24 In healthcare, this 
term can be used for settings with ‘limited access to medication, equipment and 
supplies, under-developed infrastructure and a lack of trained personnel’.25 
 
Healthcare in all contexts entails choices about resource allocation, which should be made 
based on how the population is best served. Interventions need to be planned from the 
patient’s perspective but should also be guided by public health considerations. This requires 
that the quality of care is maintained, the effectiveness of treatments is guaranteed, and the 
costs are justified. When resources are scarce, making informed decisions regarding 
allocation becomes all the more significant. 
Surgery has been called ‘the neglected stepchild of global public health’.26 However, new 
initiatives aim towards the improvement of outcomes and equity for people in need of 
surgical care.27 The publication of the Lancet commission on global surgery in 2015 provided 
evidence on the importance of surgery and possibilities to improve global health with wide-
scale dissemination.28 Further, the published research on surgery in low-income areas has 
increased substantially during the last decade.29 Recently published results of interventions 
global health
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conducted with small samples. Emergency health 
assessments also suffered from the lack of base-
lines against which to calculate excess deaths 
(Fig. 3) and calibrat  the criti ality of a it a-
tion.22
In response to growi g concerns regarding 
equity and needs-based response, public health 
analysts within the humanitarian aid commu-
nity worked to identify thresholds of key indica-
tors of mortality and malnutrition in order to 
classify situations as critical and establish trig-
gers for the provision of emergency relief.23 Rec-
ognizing the major implications of using such 
thresholds,24 a group of academics, n ngovern-
mental organizations, and UN agencies devel-
oped Standardized Monitoring and Assessment of 
Relief and Tra sitions (SMART), a rapid cluster-
sampling method that divides the population 
into groups, or clusters, and randomly selects a 
sample among these clusters for data collection, 
in order to provide statistically sound estimates 
of mortality and malnutrition.25 Now widely used 
by relief agencies,26 this method generates com-
parable epidemiologic data to quantify crisis 
thresholds and monitor the effectiveness of the 
relief,27 strengthening the evidence-based re-
sp nse.
Collecting reliable epidemiologic information 
still presents unique challenges in these disrupt-
ed field contexts.28 Because the SMART method 
does not require household listing, it has advan-
tages over random sampling.29 However, the 
relative uncertainties of cluster sampling (lower 
levels of precision and constraints on extrapola-
tion of key variables such as mortality) can prove 
problematic, because risks are highly variable 
across small areas.30 G ven the importance of 
correctly measuring malnutrition and mortality, 
on the one hand, and the shortcomings of clus-
ter sampling in transient settings, on the other, 
alternative methods, such as lot quality assurance 
sampling (which involves taking a large number 
of unusually small random samples from each 
set in the population to determine whether they 
mee  a established standard) or collection of 
data from key informants, are increasingly used.31 
For insecure settings (e.g., in a zone of conflict), 
these lternatives show promising advantages 
because of ease of implementation and the pro-
vision of nearly real-time estimates of mortality.
Although these advances have contributed to 
a greatly improved understanding of the deter-
minants of mortality and morbidity and the ef-
fectiveness of aid, the Haiti earthquake response 
(2010) revealed persistent weaknesses in interna-
tional emergency relief, particularly with regard 
to initial assessment and coordination. An au-
thorit tive evaluation has noted the long delay in 
obtaining a “rapid” health assessment (reported 
on day 45 vs. day 12, which is the standard32), 
owing to the widespread initial chaos but also 
explicitly to the bureaucratic complexity of the 
Total mortality in period of conflict
Expected (normal) mortality
(based on factors such
as regional or preconflict death rates)
Excess mortality
(deaths attributable to the conflict in 
addition to expected [normal] mortality)
Direct combat-related deaths
(e.g., from massacres, killings, and
bombings), mostly in adults
Indirect deaths
(e.g., from epidemics, breakdown
in food supply, and inaccessibility
of health and other essential services),
mostly in civilians and children 
Figure 3. Conflict-Related Deaths.
Adapted from Guha-Sapir and van Panhuis.9
The New England Journal of Medicine 
Downloaded from nejm.org at STOCKHOLMS LANS LANDSTING on October 1, 2019. For personal use only. No other uses without permission. 
 Copyright © 2013 Massachusetts Medical Society. All rights reserved. 
  23 
have exemplified the possibilities to improve health and change policies through a shift 
towards surgical care delivery and research in resource-limited areas.30,31  
Conflict-related Injuries 
Conflict-related injuries are heterogenic and their characteristics change with the evolution of 
warfare.32 The two main types of injury mechanisms are blasts and gunshots. Globally, the 
proportion of gunshot injuries has gradually decreased, and today up to 80% of conflict-
related injuries are caused by explosions or fragments from aerial bombs, hand grenades, land 
mines or improvised explosive devices.32,33 Death is often caused by exsanguination or 
central nervous system injuries. Most non-fatal injuries are musculoskeletal, impacting 
muscles, bones, and soft tissues.34,35  
Military combatants have a different injury pattern compared to civilians, in part due to their 
use of protective equipment and access to more advanced medical support.36 Research 
initiatives for the management of combat injuries exist within the armed forces. This thesis is 
limited to civilian injuries. However, as the studies were performed at the hospital level, not 
all injury types are represented. Patients with severe injuries to the central nervous system, 
thorax or major blood vessels are absent as they generally do not survive the transport to the 
hospital.37-39 Patients with severe burns or injuries that require neurosurgery are also omitted 
as the hospitals under study do not offer this care. Consequently, these patients were 
transferred to other facilities.  
Wounds 
A wound disrupts the skin’s function as a protective barrier against the environment.40 
Normal wound healing follows a path with three overlapping stages towards wound closure, a 
mature scar, and re-epithelialisation.41 These stages are i) inflammation (days), ii) new tissue 
formation (weeks), and iii) remodelling (months). Healing is influenced by patient-related 
and wound-related factors.42 Patient-related factors include age, smoking, nutrition, anaemia, 
medications, and diseases, such as diabetes mellitus. Wound-related factors include wound 
size, ischemia, the extent of devitalised tissue, and the presence of any foreign material or 
infectious agents. In addition, wound healing is affected by healthcare-related factors, such as 
surgical and antimicrobial treatment, and patient compliance with treatment protocols  
(Figure 2).  
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Figure 2. Factors Influencing Wound Healing. Modified with Permission from Wounds 
International,43 Copyright Wounds International. 
Conflict-related wounds are mainly caused by an explosion or a projectile. A projectile is a 
fragment or a bullet penetrating the body causing a wound tract. This tract is surrounded by 
devitalised tissue caused by the pressure wave. In addition, the pressure wave generates a 
vacuum, drawing contaminated particles, including bacteria and foreign materials, into the 
wound tract.32  
Wound Infection 
The devitalised tissue and contaminating particles lead to an increased risk of infection.44,45 
Irrigation, mechanical cleaning, and antibiotic treatment limit infectious complications. Still, 
infection remains a major risk for short- and long-term morbidity and mortality.46 It is 
essential to differentiate between contamination, colonisation and infection and refrain from 
overuse of antibiotics. Contamination and colonisation differ in the presence of non-
replicating or replicating microorganisms, respectively. Infection is characterized by the 
presence of replicating microorganisms that cause a host response, leading to tissue damage 
and subsequent host injury.42 Local signs of infection include purulent discharge, increased 
pain, and redness.47,48 
The pathogenic microbiota of a wound in a hospitalised patient evolves with time and can be 
summarised in three stages: environmentally acquired, self-contamination from the skin or 
gastrointestinal tract, and healthcare-associated infections (HAIs).32 There are three main 
groups of bacteria that contaminate conflict-related wounds: i) Gram-positive pyogenic cocci, 
part of the normal skin flora, including Staphylococcus aureus and β-haemolytic streptococci; 
ii) Gram-negative bacilli, primarily from the gastrointestinal tract, such as Escherichia coli, 
Proteus, Klebsiella, Pseudomonas, and Bacterioides. This group also includes Acinetobacter 
HARD-TO-HEAL WOUNDS: A HOLISTIC APPROACH
3
The environment in which an individual patient’s wound exists is affected by a number of
physical (such as underlying pathology, comorbidities, etc), psychological and social factors. 
It has been shown that physical factors, such as diabetes mellitus, obesity, malnutrition,
old age (over 60), decreased perfusion, peripheral vascular disease, malignancy, organ
failure, sepsis, and even restrictions in mobility, have an impact on healing1. Correcting,
where possible, the underlying wound pathology and any comorbidities is, therefore, a
central feature of wound management. If the underlying disease cannot be corrected or is
difficult to manage, wound healing can be delayed. 
Marston et al7 found that improved glycaemic control positively influences wound
outcome in diabetic foot wounds, particularly when dermal substitutes are used. Similarly,
it has long been recognised that restoration of pulsatile blood flow, by either surgery or
angioplasty, markedly improves the outcome in ischaemic lower limb ulceration. This is in
contrast to the situation in venous ulceration, where early surgical correction of superficial
venous reflux has proved to be no more beneficial than high compression bandaging. The
nefit of surgery here, as was demonstrated in the ESCHAR study, is in the reduction of
ulcer recurrence in both the short- and the long-term8. 
Diseases and treatments that directly affect the immune system have a major impact on
wound heali g and often increase the complexity of the wound9,10. The inflammatory
process is an integral part of acute wound healing, and derangement of this process is
recognised as one of the primary causes of wound chronicity. Immunodeficiency states,
the use f immu osuppressant drugs such as corticosteroids, azathioprine or
methotrexate, or the presence of diseases (such as diabetes mellitus) that are known to affect
the immuno-inflammatory response, all adversely affect healing and increase the risk of
wound sepsis9,10. 
PATIENT-RELATED
FACTORS
Patient-related
physical factors
Patient-related 
factors 
Potentially 
'hard-to-heal' wound
Pain
Re-evaluate progress regularly
may become 'hard-to-heal'
Allergy
Comorbidity
Medication
Psychosocial
Unlikely to be a 
'hard-to-heal' wound
Treatment progress: failure to progress 
despite appropriate 'standard' care
Treatment progress: improving 
with appropriate 'standard' care
Concordance
Pathology
Skill Knowledge
Diagnostic
Therapeutic
Interventional
Inflammation/infection
Treatment response
Resource/
treatment-related
factors
Healthcare system
Availability
Suitability
Effectiveness
Cost/
reimbursement
Process of care
● Establish goals
● Address
 – patient-related factors
 – wound-related factors
● Instigate treatment
● Review progress
Size (area and depth)
Wound bed condition
Ischaemia
Duration/senescence
Wound-related 
factors
 Healthcare
professional 
Review:
● Diagnosis
● Circumstances
● Treatment
● Progress
● Care method
● Options
● Referral
Wound complexity increases 
the likelihood of hard-to-heal status 
Anatomical site
Figure 1 | Factors that
may affect complexity
and hard-to-heal status
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baumannii, found on the skin and in the soil, commonly found in HAIs; and iii) Gram-
positive bacilli found in the environment, including the Clostridium species, causing tetanus 
and gas gangrene.32 
Antibiotic Resistance 
Antibiotic resistance is increasing worldwide,49 owing to the overuse and misuse of 
antibiotics.50 This development threatens the effectiveness of antibiotics, used both as 
prophylaxis and as treatment for infections. Multidrug-resistant (MDR) bacteria is a risk 
factor for persistent infection in conflict-wounded patients.51 The incidence of MDR 
organisms in civilians was found to be high, both when systematically screening all 
patients52-54 and when culturing chronic conflict wounds.55,56 MDR organisms were common 
in infected wounds among Syrian civilians with conflict-related injuries.52,55 The suggested 
sources of MDR infection in conflict-related wounds  include colonisation of the patients and 
HAIs.57 A high MDR prevalence in the study setting could partly be explained by the easy 
access to antibiotics without a prescription.58  
Surgical Management 
A Short History of Conflict-related Wound Management 
The struggle against bacterial infection can be traced throughout the history of conflict-
related wound management.59 Prior to the era of antibiotics, antiseptic techniques were 
developed which, together with effectively disinfecting surgical instruments, reduced 
mortality.60,61 The principle of removing devitalised or infected tissue and contamination, so-
called wound debridement,62 was further developed during the First World War, as described 
by the Belgian Army surgeon, Antoine Depage.63 The Penicillium mould, accidentally 
discovered by Alexander Fleming when he recognised that the mould inhibited the growth of 
staphylococci,64 was not mass-produced in the early years of the Second World War. Instead, 
the oral prophylactic administration of sulphonamides was recommended after an injury. 
Gradually, penicillin and streptomycin came into use.65 The knowledge on the bacteriology of 
wounds increased as a result of the research conducted during the war.65 In the Korean and 
Vietnam Wars, thorough debridement was found to decrease the risk of infection.66,67 Other 
management developments led to improved outcomes for wounded combatants, such as 
forward surgical care, helicopter evacuations, and vascular repairs.  
Modern Surgical Management 
The modern management of conflict-related wounds relies on irrigation, debridement,68 and 
antibiotic therapy, used both as perioperative prophylaxis and to treat wound infections.32,69 
After the stabilisation of fractures and management of any damage to vital structures, the 
wound is dressed and monitored until ready for so-called delayed primary closure (DPC), as 
early closure of the wound after debridement is associated with a greater risk of local 
infection and septic complications.70 The optimal time for DPC has not been determined and 
is based on clinical judgement, with signs of sepsis or offensive smell from the wound 
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prompting early return to the operating theatre for re-assessment.71 Current practice 
guidelines recommend DPC three to five days following injury, depending on wound 
status.32,70  
There are treatment guidelines and established best practices for traumatic injuries in high-
resource settings.72 However, a major challenge lies in how to manage high numbers of 
patients when resources are limited. To support prioritisation and allocation of resources, the 
effectiveness, utility, and cost-effectiveness of available treatment methods must be carefully 
evaluated. To assess the specific challenges related to resource-limited settings, context-
specific evidence is needed.  
Negative Pressure Wound Therapy  
Since its introduction in the early 1990s, negative pressure wound therapy (NPWT) has been 
adopted as a widespread technique in wound management.73 The technique involves a 
sterilised sponge that is fitted into the wound and covered with a plastic sheet. A hole is cut in 
the plastic and a suction device is attached, creating negative pressure. Any tissue fluid is 
drawn away and collected in a canister. Expert consensus supports NPWT for use in a variety 
of indications, including as a bridge from debridement to DPC.74 Claimed benefits include 
shortened healing time and fewer infectious complications. The airtight plastic sheet might, 
however, increase the risk of anaerobic bacterial infections. Additional risks include pain 
during dressings changes75 and bleeding from granulation tissue.76  
Attempts have been made to study the potential benefits of NPWT. However, more 
systematic reviews than randomised controlled trials (RCTs) have been published, and the 
majority of existing RCTs contain quality-related issues.77 In addition, many trials are 
financially supported and initiated by the medical device industry and are often terminated 
prematurely.78 This generates a risk of publication bias as “negative” results, i.e. results 
without evidence of effectiveness, are less likely to be published.  
Cochrane reviews of NPWT for chronic and surgical wounds have emphasised the need for 
high-quality, adequately powered clinical trials to assess effectiveness.79-81 A systematic 
review of RCTs of NPWT for the treatment of open traumatic wounds concluded that 
evidence of the technique’s effectiveness is lacking.82 Consequently, evidence from a 
carefully designed and performed RCT is necessary to establish best practices. 
Reports have been written regarding NPWT in the treatment of acute conflict-related 
wounds83-85 and the technique is now being introduced as a treatment alternative for these 
patients. However, the decision to implement a costly treatment method should be based on 
high-quality, context-specific evidence of its effectiveness as a remedy as well as its cost-
effectiveness. For NPWT, there is little such evidence to date. 
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AIMS 
 
The overall aim of this thesis is to generate knowledge on the management of conflict-
related injuries among civilians in resource-limited settings. 
The specific aims were: 
I. To compare the outcome and resource consumption of civilian patients, recieving 
surgical treatment for acute conflict-related injuries, with and without wound 
infection. 
II. To explore the challenges hospital-based physicians encounter in the management 
of conflict-related wounds among civilians, focusing on surgical intervention and 
antibiotic use.  
III. To compare the safety and effectiveness of NPWT against that of standard wound 
treatment, specifically in patients with acute conflict-related extremity wounds. 
IV. To determine the treatment-related costs and cost-effectiveness of NPWT for 
acute conflict-related extremity wounds in civilian hospital care. 
 

  29 
METHODOLOGY 
Conflict-related wound management is a complex topic that is not well-studied. Therefore, 
the most suitable research methods remain to be defined. For this thesis, I have utilised 
different approaches. Through observational research methods (Paper I), my colleagues and I 
assessed how wound infection is associated with outcomes. In Paper II, we used qualitative 
methods to explore the main challenges in conflict-related wound management. In a 
randomised clinical trial, we evaluated an intervention for wound treatment, specifically 
regarding its effectiveness and safety (Paper III), and its associated costs and cost-
effectiveness (Paper IV). Figure 3 depicts the research framework for this thesis.  
By combining different methods, each with different possible biases, the methods will ideally 
complement each other and thus result in an improved overall body of evidence. This 
rationale is in line with the concept of methodological triangulation.86 
 
Figure 3. Research Framework. Modified with permission from Wounds International,43 
Copyright Wounds International.  
Study Areas 
Data collection for all papers (I–IV) was initiated in 2015 at the civilian Ministry of Health 
hospital in Ar Ramtha, Jordan (Figure 4). This hospital is located near the Syrian border and 
is supported by the international non-governmental organisation (NGO) Médecins Sans 
Frontières/Doctors Without Borders (MSF). In June 2016, the Syrian border was closed 
following a border control attack. At that time, data collection was complete for Papers I and 
II; however, we had not yet reached the target number of patients for the randomised trial 
(Papers III and IV). We began searching for an additional location at which the trial could be 
HARD-TO-HEAL WOUNDS: A HOLISTIC APPROACH
3
The environment in which an individual patient’s wound exists is affected by a number of
physical (such as underlying pathology, comorbidities, etc), psychological and social factors. 
It has been shown that physical factors, such as diabetes mellitus, obesity, malnutrition,
old age (over 60), decreased perfusion, peripheral vascular disease, malignancy, organ
failure, sepsis, and even restrictions in mobility, have an impact on healing1. Correcting,
where possible, the underlying wound pathology and any comorbidities is, therefore, a
central feature of wound management. If the underlying disease cannot be corrected or is
difficult to manage, wound healing can be delayed. 
Marston et al7 found that improved glycaemic control positively influences wound
outcome in diabetic foot wounds, particularly when dermal substitutes are used. Similarly,
it has long been recognised that restoration of pulsatile blood flow, by either surgery or
angioplasty, markedly improves the outcome in ischaemic lower limb ulceration. This is in
contrast to the situation in venous ulceration, where early surgical correction of superficial
venous reflux has proved to be no more beneficial than high compression bandaging. The
benefit of surgery here, as was demonstrated in the ESCHAR study, is in the reduction of
ulcer recurrence in both the short- and the long-term8. 
Diseases and treatments that directly affect the immune system have a major impact on
wound healing and often increase the complexity of the wound9,10. The inflammatory
process is an integral part of acute wound healing, and derangement of this process is
recognised as one of the primary causes of wound chronicity. Immunodeficiency states,
the use of immunosuppressant drugs such as corticosteroids, azathioprine or
methotrexate, or the presence of diseases (such as diabetes mellitus) that are known to affect
the immuno-inflammatory response, all adversely affect healing and increase the risk of
wound sepsis9,10. 
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expanded. An opportunity arose in Erbil, Iraq, at a civilian hospital run by the local NGO 
Emergency Management Center (EMC) (Figure 5). This hospital received patients from 
Mosul during the armed conflict between 2016 and 2017.87 When the Syrian border was re-
opened in November 2016, we resumed patient enrolment in Jordan, but this was suspended 
again in February 2017.  
 
Figure 4. Ar Ramtha Hospital, Jordan. Photo: Andreas Älgå 
 
Figure 5. Emergency Management Center, Iraq. Photo: Andreas Älgå 
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Consequently, the patients included in this thesis were from Syria and Iraq. These countries 
are heavily affected by armed conflict, with a life expectancy approximately 15 years shorter 
than that of Sweden (Figure 6). We chose study areas with reasonable stability and security, 
albeit with proximity to armed conflict, providing unique preconditions for a clinical research 
project. Both EMC and Ar Ramtha Hospital were equipped with an operating theatre, 
autoclave, and computer tomography. Each hospital had a basic laboratory but did not have 
the facilities to perform microbiological cultures or analyses. For Paper I, an external 
laboratory was used. Specialist doctors were anaesthesiologists and general or orthopaedic 
surgeons. Angiography or endovascular capabilities were not available, nor were specialists 
in vascular-, thoracic-, plastic-, or neurosurgery. Prophylactic antibiotics were available. 
However, more advanced antibiotics, such as the rifampicin, were unavailable (Paper II).  
 
Figure 6. Life Expectancy and Income per Capita Arranged by Country, 2018. Free material 
from www.gapminder.org. 
Jordan and the Syrian Armed Conflict, Papers I–IV 
Syria is a low-income country (Figure 7).88 The Syrian armed conflict started in 2011 and 
rapidly deteriorated into what has been described as ‘the worst man-made disaster the world 
has seen since World War II’.89 To date, the conflict has claimed 350 000 lives; over 4 
million Syrians have been forced to migrate, primarily to neighbouring countries.16 The 
upper-middle-income country, Jordan, now hosts 655 000 Syrian refugees.88,90 At Ar Ramtha 
Hospital, patients with acute injuries from the Syrian armed conflict are treated. Wounds are 
managed in accordance with the International Committee of the Red Cross (ICRC) 
protocols.32 
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Figure 7. Study Areas. Copyright Google Maps. 
Iraqi Kurdistan and the Battle of Mosul, Papers III–IV 
Iraq is an upper-middle-income country.88 Since the current state of Iraq was formed in the 
early 1930s, not one decade has passed without the country experiencing armed conflict. In 
the mid-2010s, militant Islamist groups like Al-Qaeda and the Islamic State of Iraq and Syria 
(ISIS) increasingly gained control in Iraq. Between 2016 and 2017, an Iraqi-led coalition 
reclaimed the city of Mosul from ISIS. EMC was a key medical facility that received people 
injured in the conflict.87 The hospital is designated to treat patients with conflict-related 
injuries. 
Study Populations 
The population in Paper I consists of 457 consecutive patients who were admitted to Ar 
Ramtha Hospital from September 17, 2014, to June 21, 2016, and received surgical treatment 
for acute conflict-related trauma (Table 1). The availability of standardised culture results 
established the start of the study, and closure of the Syrian border determined the end.  
  
  33 
Table 1. Overview of the Included Papers 
 Paper I Paper II  Paper III  Paper IV 
Study 
Period 
2014–2016 2015 2015–2018 2015–2018 
Design  Cohort study  Qualitative 
interview study  
Randomized 
controlled trial 
Health economic 
evaluation 
Participants  Patients having 
surgery for 
conflict-related 
injuries, Ar 
Ramtha  
Physicians, Ar 
Ramtha  
Patients with 
conflict-related 
extremity 
wounds, Ar 
Ramtha and 
EMC  
Patients with 
conflict-related 
extremity 
wounds, Ar 
Ramtha and 
EMC 
Number 457 10 165 165 
Data 
Sources 
Routinely 
collected clinical 
data  
Semi-structured, 
face-to-face 
interviews  
Case report 
forms 
Case report 
forms, hospital 
end-of-year 
report 
Main 
Analysis 
Methods 
Logistic 
regression 
models 
Content analysis Standard 
analysis in 
accordance with 
CONSORT91 
Cost and cost-
effectiveness 
analyses92 
Main 
Outcome 
Measures 
Clinical 
outcomes and 
resource 
consumption  
Perceptions of 
challenges in 
wound 
management 
Wound closure 
by day five and 
net clinical 
benefit 
Treatment-
related costs  
and cost-
effectiveness 
EMC, Emergency Management Center. CONSORT, Consolidated Standards of Reporting 
Trials. 
The ten participants in Paper II were recruited in 2015. They all worked for MSF at Ar 
Ramtha Hospital, five as general or orthopaedic surgeons and five as general doctors in the 
emergency room or on the ward. The participants were selected through purposeful sampling 
aiming at heterogeneity in terms of age, sex, country of origin, medical specialty, and years of 
work experience (Table 2).  
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Table 2. Characteristics of the Ten Participants in Paper II 
Age, median (IQR) 31 (29–39) 
Male, n (%) 6 (60) 
Origin, Jordan (non-Jordan) 6 (4) 
Medical specialty, general or orthopaedic surgeon (not specialised) 5 (5) 
Years of work experience, median (IQR) 6 (4–13) 
IQR, interquartile range. 
For Papers III and IV, participants were recruited between June 9, 2015, and October 24, 
2018, at Ar Ramtha Hospital and EMC. A total of 278 patients were eligible for participation 
(Figure 8). One patient declined. Some 103 patients were either deemed unsuitable by the 
responsible surgeon or were not included for other reasons, i.e. they were admitted during a 
mass-casualty situation, were transferred to other hospitals, or the study nurses were not 
informed when they arrived at the hospital. Consequently, 174 patients were randomised. 
Nine patients were excluded; either because we could not obtain delayed consent, or because 
the patients did not fulfil the inclusion criteria, died, or left the hospital against medical 
advice. A total of 165 patients (67 from Ar Ramtha, 98 from EMC) remained for the 
intention-to-treat analysis. 
Figure 8. Flow Chart. NPWT, negative pressure wound therapy. LAMA, left against medical 
advice.  
278 eligible patients
174 enrolled
104 eligible patients not enrolled
44 mass-casualty
28 nurses were not informed or unavailable
20 surgeon decision 
8 unsuitable due to vascular repair
3 transfer to other hospital after surgery 
1 no consent
174 randomised
88 allocated to
NPWT
86 allocated to 
standard treatment
82 analysed by 
intention-to-treat
4 withdrawn before primary endpoint
1 unable to consent before 5 days 
1 died before 5 days
1 LAMA before 5 days
1 excluded (not conflict-related)
82 received treatment
82 received standard treatment
0 received NPWT 
83 received treatment
80 received NPWT
3 received standard treatment
(due to technical issues)
83 analysed by 
intention-to-treat
5 withdrawn before primary endpoint
2 unable to consent before 5 days
1 died before 5 days
1 arrested by the police before 5 days
1 excluded (not extremity wound)
9 discontinued treatment
3 transfer to other hospital
2 permission
2 partial closure
1 closure failure
1 surgeons decision
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Study Design and Methods 
Paper I 
The seed of Paper I was planted during my first visit to Ar Ramtha. At the MSF office next 
to the hospital, I was presented with a folder containing wound cultures for all patients with 
clinically infected conflict-related injuries treated at the hospital. Inspired by the potential of 
this data set, we developed a cohort study protocol to compare patients with wound infection 
to those without, and to assess if the groups differed in terms of clinical outcomes and 
resource consumption. After ethical approval, we started building a database of these culture 
results and clinical information extracted from a pre-existing MSF database. We collected 
both retrospective and prospective data. 
Surgeons obtained intraoperative samples (fluid, soft tissue, or bone) only from wounds with 
clinical signs of infection. Details on bacterial species and their resistance patterns were 
extracted from wound culture reports. MDR was defined as resistance to at least one 
antibiotic from three or more relevant antibiotic groups.93 Methicillin-resistant 
Staphylococcus aureus (MRSA) was considered as MDR.  
One strength of using routine clinical data was that, to a large extent, it was readily available 
in a computer database; however, there were some limitations. First, outcome measures were 
limited. Available data included length of hospital stay, number of surgeries, limb 
amputations, and inpatient death. Outcome measures that would have been interesting to 
study involved data on the type and duration of antibiotic treatment, septic complications, and 
the number of days spent in the intensive care unit. Second, limited baseline characteristics 
were available. Details on previous medical history and medications, vital signs on 
admission, injury mechanism, and injury severity score would have been relevant to include. 
With the aim to assess injury severity as a confounder, one of our study nurses localised the 
paper files for all 49 patients with wound infection, and non-infected controls were matched 
according to age and sex. We then calculated the coded Revised Trauma Score (RTSc)94 from 
the respiratory rate, systolic blood pressure, and Glasgow Coma Scale (GCS)95 scores. The 
mean RTSc in cases was then compared to the controls. Third, we had to rely on local 
definitions of clinical signs of infection and trust the adherence to those guidelines. Wound 
infection was defined as clinical signs of infection and at least one positive culture. This 
definition, however, might have been too strict and was adjusted for Paper III to only include 
clinical signs, defined as purulent discharge,47 disregarding confirmation by wound culture. 
Another strength of the study was the use of an accredited clinical microbiology laboratory 
that utilised well-established analysis techniques and interpretation guidelines.96 The findings 
in Paper I were reported according to the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) statement.97  
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Paper II 
Due to the explorative nature of Paper II, we concluded that a qualitative study design using 
interviews and subsequent content analysis would be suitable. Qualitative methods enable the 
researcher to describe, interpret, and generate theories on the experiences of individuals and 
the specific contexts in which they took place.98 These methods are used to answer questions 
difficult to approach quantitatively, mainly focusing on the ‘how?’ and ‘why?’.99 Data is 
often gathered through interviews. An inductive analysis is commonly used to derive the 
broader meaning from the interview material. A deductive approach will utilise a pre-existing 
perception, guideline or theory for continuous comparison throughout the condensation and 
abstraction processes. We used the protocols for wound care, hygiene, and antibiotic 
treatment from Ar Ramtha Hospital for the deductive analysis. Subsequently, our goal was to 
analyse both manifest and latent content. Manifest content is defined as the concrete meaning 
of a text, whereas latent content refers to the interpreted underlying meaning.  
In the area of conflict-related wound management in civilians, there is a dearth of qualitative 
research and no studies have been published as yet on the experiences of physicians in this 
context. Our aim was to explore physicians’ experiences by letting the participants freely 
present their views and then elaborate. This has been shown to be an effective design to 
generate knowledge that cannot be obtained through quantitative methods.100 We reported our 
findings in accordance with the standards for reporting qualitative research (SRQR).101  
Paper III 
Expatriate surgeons from the United States who were working for MSF at Ar Ramtha 
Hospital had requested the introduction of NPWT for patients with hard-to-heal traumatic 
wounds. I was approached by MSF Sweden and asked to facilitate the evaluation of NPWT 
in terms of feasibility, safety, and effectiveness. At first, I was somewhat reluctant due to the 
costs associated with NPWT and the limited evidence of its effectiveness. However, I 
concluded that an uncertainty of effect, i.e. clinical equipoise, is to be considered an ideal 
starting point for an RCT.102 In addition, the introduction of NPWT for civilians with 
conflict-related wounds was discussed at the time, both within MSF and the ICRC. Once an 
intervention has been established as part of routine treatment, questioning its indication and 
conducting a clinical trial becomes much more problematic. Therefore, the time was limited 
to initiate an adequately powered RCT to evaluate the safety and effectiveness of NPWT for 
this patient group.  
We designed a pragmatic, randomised, controlled, superiority trial (Paper III). The purpose 
of a pragmatic trial is to inform real-world healthcare decisions by designing the trial so that 
most patients with the studied condition will be eligible, using non-strict inclusion criteria and 
few exclusion criteria.103 We considered adult patients (≥18 years) with acute conflict-related 
extremity wounds (≤72 h) in need of surgical debridement as eligible (Figure 9). Patients with 
a wound suitable for primary closure were not included. We used block randomisation with 
three fixed block sizes (4, 6, 8). Paper envelopes were prepared by one member of the 
research team who was not involved with randomisation or treatment. At the end of the first 
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surgery, the participants were randomly assigned to NPWT (a commercial NPWT device 
with a continuous negative pressure of 125 mm Hg) or standard wound treatment (wound 
dressings with non-adhesive sterile gauze covered with a bandage) according to the ICRC 
war surgery protocol.32 Apart from the wound treatment methods, the same perioperative 
routines and materials were used for all participants. Fractures were immobilised by using 
external fixation. All participants received narrow-spectrum antibiotic prophylaxis.  
 
Figure 9. Patient with an Acute Conflict-related Extremity Wound. Published with Patient 
Permission. Photo: Murad Alrawashdeh 
Patients were sometimes transported from the emergency room to the operating theatre for 
emergency surgery without full consciousness, circumstances that often provided insufficient 
time and opportunity to obtain informed consent before surgery. We therefore utilised the 
principle of delayed consent.104 Participants undergoing acute surgery entered the study under 
presumed consent. They were subsequently informed as soon as appropriate during the 
postoperative period and written consent for continuation in the trial was collected. Three 
patients were unable to provide delayed informed consent within five days after 
randomization; these patients were excluded from the intention-to-treat analysis.  
The nature of the treatment methods precluded blinding of the patients or staff involved. Two 
independent clinicians, blinded to treatment allocation, evaluated the wound photographs. 
Data were collected at each dressing change, at hospital discharge, and at days 14 and 30 
following the day of randomisation. We defined wound closure as closure by flap, suture, or 
split-thickness skin graft. The primary endpoint was wound closure by day five. The 
coprimary endpoint was net clinical benefit, defined as a composite of wound closure by day 
five, and freedom from any bleeding, wound infection, sepsis, or amputation of an index 
limb. The trial was registered online at ClinicalTrials.gov (NCT02444598)105 and the research 
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protocol was peer-reviewed and published.106 The study was carried out, analysed, and 
reported in accordance with Consolidated Standards of Reporting Trials (CONSORT) 
guidelines for randomised and pragmatic trials.91,103  
The observational study design of Paper I is often used to measure the effectiveness of an 
intervention in a ‘real-world’ scenario, as compared to the controlled study setting of an RCT. 
In general, observational studies are considerably less costly and time-consuming compared 
to RCTs and have been shown to result in similar findings.107 However, some biases and 
confounders cannot be controlled for without randomisation.108 The random allocation to 
treatment groups accounts for known and unknown confounders and generates two groups 
with balanced characteristics. In a large enough RCT, the only thing that should be non-
identical between the groups is treatment allocation. The intention-to-treat analyses aim to 
preserve this random allocation by basing the analyses on the original treatment assignment 
and not the treatment (if any) received. This strategy should minimise the effect of non-
random dropouts or treatment crossover. In conclusion, the randomisation process and 
intention-to-treat analyses should assure clear, unbiased evidence. RCTs are therefore 
considered a robust method to assess the effectiveness of an intervention, while real-world 
studies can be viewed as hypothesis-generating.109 
Surgical research generally consists of retrospective case series.110,111 In the peer-reviewed 
literature, it has been reported that less than 10% of all surgical articles report the results of 
RCTs.112 Surgical interventions are half as likely to be based on RCTs than medical 
therapies.113,114 In a field with rapid technological advances and new surgical interventions, it 
is largely the responsibility of the research community to generate high-quality evidence to 
evaluate the safety and effectiveness of such new techniques. In a recent a review of the 
evidence on NPWT, less than 1% (n=27) of the 3 287 identified publications were RCTs with 
clearly defined endpoints.73  
Paper IV 
Health economic evaluations may be defined as ‘comparative analyss of alternative courses 
of action in terms of both their costs and consequences’92 and can help guide the allocation of 
healthcare resources. Before a treatment method is implemented in a resource-limited setting, 
its effectiveness should be i) proven and ii) found to justify the costs involved. When 
designing Paper III, we concluded that the logical next step after the assessment of the safety 
and effectiveness of NPWT would be a health economic evaluation. Health economic 
evaluations of NPWT versus standard wound treatment exist, but as most of these analyses 
are based on trials with methodological weaknesses, the evidence value of their conclusions 
are limited, hence, cost and cost-effectiveness of NPWT need to be further analysed.77 
Economic evaluations of NPWT, as an alternative to the standard treatment of traumatic 
wounds, are scarce. To date, there are only two analyses based on randomised data and one is 
included in this thesis (Paper IV). The other found no evidence of cost-effectiveness.82  
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Within the health economy framework, the three alternative assessment methods available 
were a cost-benefit analysis, a cost-minimisation analysis, or a cost-effectiveness analysis. 
For cost-benefit analyses, health effects are valued in monetary terms. Based on the nature of 
the outcome data from Paper III, we concluded that this method was not a suitable option. A 
cost-minimisation analysis implies that two treatments result in equivalent health effects, and 
is typically utilised for data derived from non-inferiority trials.115 Although Paper III reports 
‘negative’ results, we cannot exclude the possibility of important differences in treatment 
effects. It is important to bear in mind that ‘absence of evidence is not evidence of 
absence’.116 Consequently, a cost-minimisation analysis was not considered an appropriate 
methodological choice.117 Cost-effectiveness calculations incorporates both the cost and the 
health effects of two treatments. The health effects are valued in nonmonetary units. We 
decided to perform a cost-effectiveness analysis, despite a non-significant difference in 
treatment effects (Paper III). 
We conducted an analysis of costs from the perspective of the healthcare provider,92 covering 
overhead and capital costs, and costs for staff, medicines and materials. We included the costs 
of services delivered to the participants admitted to the hospital, including the costs of 
surgeries and care given on the ward. Costs per surgical procedure were calculated based on 
the total number of procedures per year. Costs for postoperative care were calculated as cost 
per hospital day based on the yearly costs for all admitted patients. We used cost data from 
EMC, where the information was readily available. In addition, EMC exclusively treats 
patients with conflict-related injuries, thus reducing the risk of a larger surgical panorama that 
might have affected the health economic analysis. We used outcome data until 30 days after 
randomisation. We excluded costs for the treatment of chronic wounds (defined as non-
closure within 30 days) in the analysis. The primary and coprimary endpoints of Paper III 
were used as health outcomes. To challenge the data used in the analysis, we performed 
sensitivity analyses for hospital productivity level, staff and hospital costs, the capital cost for 
the NPWT pumps, and the depreciation time of the NPWT pumps. The study findings were 
reported in accordance with the Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS) guidelines.118 
Data Collection and Management 
Data for this thesis were stored at a protected server at Karolinska Institutet. The use of 
identification numbers ensured the anonymity of the data. With the use of encryption 
methods, all data remained confidential throughout the data entry and analysis process. 
The data used in Paper I was limited to routinely collected clinical data. Data were extracted 
from a clinical patient database, paper-based patient files and wound culture reports. To 
ensure full quality control and traceability of our data, we used designated data management 
software, Epidata Entry (The Epidata Association, Odense, Denmark). This software is free 
to download (www.epidata.org) and thus suitable for use in resource-limited settings. An 
extensive data-check operates during the data entry process. By tracking all changes, random 
errors can be identified and corrected.  
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The data for Paper II were collected through semi-structured, face-to-face interviews. We 
constructed an interview guide with questions and probing areas. I handled all interviews and 
thus was able to observe each interviewee’s body language and gestures. The interviews were 
recorded, and the interview guide was discussed within the research group. When necessary, 
the guide was adjusted in-between interviews. We included participants until saturation was 
reached, i.e. when further data collection was not found to contribute new information 
regarding the main topics. Eleven medical doctors were invited to participate and they all 
consented to the study. The recorder malfunctioned during one interview, which had to be 
excluded. One interview was terminated in advance because the participant needed to attend 
clinical work. As a consequence, this interview is shorter than the others, but it was included 
in the analysis process. In total, ten interviews were analysed. The duration of the interviews 
ranged from 13 to 50 minutes, with a mean duration of 32 minutes. 
In Paper III, all data were primary data, collected prospectively on paper-based case report 
forms (CRFs) in accordance with Good Clinical Practice (GCP).119 The data were quality-
controlled for completeness by the primary investigator; an external monitor regularly 
reviewed unblinded data. The paper-based data were entered into a database using the 
Epidata Entry software. Through double entry, we minimised the risk of random errors from 
manual entry. Data were thoroughly checked for consistency and plausibility.  
In Paper IV, we utilised clinical outcome data derived from Paper III. Data used for the cost 
analysis were collected from the EMC end-of-year report, payroll, and measurements of the 
hospital area. The participating surgeons and nurses provided additional information, for 
example, meal costs and land-leasing prices in Erbil city.  
Statistical Analysis 
For Paper I, the mean with standard deviation (SD) was used for summarising scale 
variables, and proportions with 95% confidence intervals (95% CI) for categorical variables. 
We used t-test to compare scale variables and bivariate analyses with Chi-square to compare 
two categorical variables. Binary logistic regression models were used to evaluate differences 
in outcomes and resource consumption between patients with and without infections.  
For Paper III, we based the sample size calculation on the expected rate of participants 
reaching the primary endpoint of 75% in the NPWT group and 50% in the control group. We 
considered a 25% difference clinically significant. At a significance level of 5%, we 
calculated that 58 participants per treatment group would give the study 80% power. 
Considering the nature of the study setting, we anticipated dropout levels higher than what 
might be expected in other trials. To adjust for dropouts, we therefore aimed to enrol a total 
of 200 participants. 
The analysis was done by intention to treat and no interim analyses were carried out. We 
reported continuous variables as a median with an interquartile range (IQR), and categorical 
variables as numbers and proportions. We computed the between-group differences in 
categorical variables by employing Fisher’s exact test. Two-sided 95% CIs were calculated 
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for the absolute differences in the proportions of the outcomes, according to the method of 
Jeffreys.120 We estimated time-to-closure with the Kaplan-Meier (KM) method, and we used 
the Mantel-Haenszel log-rank test to compare the KM cumulative incidence curves. We 
applied a standard Cox proportional hazards model for estimating the relative chance of 
closure (hazard ratios [HRs] and 95% CIs) with the standard dressing group used as the 
reference. Inspection of log–log plots and a global test based on Schoenfeld residuals 
indicated that the proportional hazards assumption was not violated.  
The analysis in Paper IV was by intention to treat. We used the Mann-Whitney U test or a 
two-sample test for equality of proportions to detect differences in characteristics and 
outcomes between the two study arms. For this thesis, a two-sided P<.05 was considered to 
indicate statistical significance. We analysed data using SPSS Statistics (IBM Corp., 
Armonk, New York, USA) and R version 3.5.0 software.121 
Qualitative Analysis 
For Paper II, we used content analysis as described by Graneheim and Lundman.122 The 
interviews were transcribed verbatim. Subsequently, the transcribed interviews were read and 
re-read in their entirety to grasp the overall content and to correct mishearing and 
misinterpretations. For the content analysis, we first identified meaning units, defined as 
words, sentences or paragraphs related by their context or meaning. If needed, we then 
condensed the meaning units. Subsequently, we developed codes, sub-categories, and 
categories by both deductive and inductive approaches. We conducted the analysis primarily 
using tables in Microsoft Word® 2011 (Microsoft, Redmond, Washington, USA). We 
implemented member-check during the interview period, where I continuously reviewed the 
material and, if clarification was needed, went back to the participants to completely 
understand the content. We used peer-check during the analysis and the writing processes 
through consultation with experienced qualitative researchers. 
Role of the Funding Source 
This is an investigator-initiated research project. No commercial companies were involved in 
the study design, the interpretation of data, or the writing of the reports, nor did any 
companies contribute funding.  
Ethical Considerations 
The procedures for Paper I were limited to the analysis of routinely collected clinical data. 
The primary risk generated by the retrospective data analysis was a breach of data 
confidentiality. With the above-described data protection strategies, the risks of harm were 
considered minimal. The potential benefit for future patients by the generated knowledge 
therefore justified proceeding with the study. The participants of Paper II all provided written 
informed consent, and were informed that they could withdraw from the study at any time. It 
could be argued that some of the matters discussed could be considered as sensitive. 
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However, anonymity and confidentiality were assured. As the participants were physicians, 
the power between the researcher and the participants was considered well-balanced. 
The main ethical considerations pertain to Paper III. The introduction of a relatively new 
intervention in resource-limited settings must be done with care. ‘Failing to match technology 
to local needs and abilities’ has been mentioned as one of the seven sins of humanitarian 
medicine.123 However, it may be considered unethical to exclude casualties of armed conflict 
from research and thus refrain from the generation of knowledge imperative for the 
optimisation of the relevance and effectiveness of the healthcare provided to these 
populations.124 In areas where a local ethics committee is absent or sub-standard, an external 
independent committee might be useful. For our studies (Papers I–IV), in addition to the 
Jordanian and Iraqi ethics committees, we utilised the independent MSF ethics review 
board.125  
It has been argued that moving clinical trials to low- and middle-income countries to 
minimise research costs could be a violation of international human rights or humanitarian 
law.126 There is a need of research within these populations; however, it should be health-
promoting and not lead to excess risks. A thorough risk-benefit analysis with identified 
benefits for the population studied is essential before initiating such research projects. In 
addition, attention should be paid to the dissemination of study results. To reach the actors 
involved in improving the care for patients with conflict-related injuries, publication in open-
access journals is an option to be considered. 
Patients eligible for inclusion in the RCT were sometimes illiterate or in a position of 
dependence, and thus were at a risk of feeling obliged to participate in the trial. We provided 
written and oral information in English and Arabic to eligible patients, including details on 
their right to withdraw from the study and issues concerning confidentiality. No incentives 
were provided to any participant. We collected written informed consent from each 
participant before randomisation or obtained delayed consent within five days of 
randomisation.  
The principle of delayed consent has been established in large trials that include critically ill 
participants.127-129 Ethically, the use of delayed consent has been questioned, and some ethics 
committees do not allow this practice.127 Researchers have used hypothetical scenarios to 
confirm the acceptability of delayed consent among relatives of critically ill patients.130-132 
One questionnaire study among patients enrolled in a trial using delayed consent found that it 
was considered acceptable from participants’ perspectives.104 The intervention under 
investigation in Paper III, NPWT, is a well-established treatment and not to be considered 
experimental. In addition, prior to study initiation, the implementation of NPWT in Ar 
Ramtha as a standard treatment option was discussed, making the use of delayed consent less 
controversial. All trial procedures adhered to the GCP guidelines and an external monitor 
regularly reviewed unblinded data in confidence. 
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Paper IV was limited to secondary analyses of aggregated outcome data derived from Paper 
III and additional non-sensitive data for cost calculations. The potential risks for study 
participants are therefore considered to be minimal. 
Formal competencies were acquired through courses in GCP and ethics in global and public 
health research. We held regular ethical discussions at the research sites, and local researchers 
received online GCP training. 
All study procedures adhered to the Declaration of Helsinki.133 Ethics approval was obtained 
from the Ethics Review Committee of the Jordanian Ministry of Health (MOH REC 150037) 
(Papers I–IV), the Ethics Review Board of MSF (ID 1520) (Papers I–IV), the Research 
Ethics Committee, Kurdistan Regional Government in Iraq (2:10 6/3/2017) (Papers III–IV), 
and the Swedish Ethical Review Authority (2019-01975) (Papers III–IV). The proceedings in 
the MSF ethics approval included a yearly re-application for renewal. 
Personal Fieldwork Reflections 
I came into this project with a rather naïve idea that things would work out easily, and that the 
studies would run smoothly. This feeling was enforced by the positive attitude expressed by 
the MSF staff, especially within the MSF Sweden Innovation Unit. However, research will 
probably never have priority within an MSF project, and rightly so. 
The opportunity to conduct research in cooperation with an international NGO has been a 
privilege but also a challenge in many ways. MSF is an organisation full of action-driven, 
passionate people who do not fear starting new projects. This has been a very helpful 
approach on this journey towards a common goal: to find an answer to the question of 
whether NPWT is better than standard treatment. However, sometimes there is a sense that 
NGOs and medical universities speak two different languages. It is understandable that a 
humanitarian organisation accustomed to making quick decisions will expect a clinical study 
to provide results that are directly applicable at the patient level. However, a research project 
is not a quick fix. The initial assessment by the Ar Ramtha office was that data collection 
would take six months at the most. In the end, a study period of over 40 months, including the 
expansion into another country, was required before data collection was finally complete. By 
the time we had cleaned the data and could present some preliminary results, the Ar Ramtha 
project had been closed for more than a year. 
It should be noted that, considering the complexity of the project and study settings, the 
length of the data collection period is not surprisingly long. However, expectations on both 
sides of the collaboration could have been more realistic and more thoroughly discussed 
during the planning stage. 
In June 2014, I had never heard about the MSF project in Ar Ramtha, Jordan. The idea of 
performing an RCT there was first discussed with the MSF Sweden Innovation Unit in July 
2014, and quickly developed into a collaborative effort. In January 2015, I embarked on my 
first field visit to Ar Ramtha and, in February 2015, the first draft version of the study 
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protocol was finalised. After ethical approvals were gained, the first patient was recruited in 
June 2015. Without enthusiasm, a strong will, and local support, going from first discussions 
to patient enrolment in an RCT within an armed conflict setting in less than one year would 
never have been possible. 
Challenges  
The main challenges of this project were related to patient enrolment, a high turnover of 
surgeons, the sudden influx of high numbers of wounded patients, unanticipated complicated 
injuries, the transfer of information, and, at times, limited access to the hospital—both for 
patients and for researchers. 
Lessons Learned  
For a complex research project like this one, it is essential to base decisions on first-hand 
information. I had begun drafting a study proposal based on emails, internal reports, and 
Skype conferences only to find that, when I finally reached the capital of Amman, Jordan, 
this information was, to a large extent, obsolete. I met with the Head of Mission and the 
medical coordinator and was thoroughly briefed. The next day, I travelled to the hospital in 
Ar Ramtha. Upon arrival, I quickly realised that only at the study site would I be able to 
understand the whole picture. 
I talked to the patients spent time with the doctors and nurses at the hospital. Many had 
questions and some were sceptical, but most were enthusiastic. I made sure to take the time to 
answer all questions and to explain, and I tried to earn their trust. The idea of testing this 
specific new method for wound treatment came from the surgeons at Ar Ramtha Hospital. 
This proved to be a major advantage when seeking acceptance for this type of project, which 
requires advocates at the study site—especially when the primary investigator may be 
somewhere else, in my case on another continent. 
Another necessity is a strong local research team, if possible with a link to local academia. 
This was in our case, Jordan University of Science and Technology in Irbid. However, the 
most critical factor for this type of project is the study nurses. They engage in the day-to-day 
challenge of enrolling patients in the study. By taking the time to recruit dedicated study 
nurses, half the battle is won. Right after my return from Ar Ramtha, I started working on the 
study protocol, applications for the ethical review committee, and a study-nurse job 
description. At the second visit, we recruited our first study nurse and initiated patient 
enrolment. We had developed a study protocol with a pragmatic design—just a few clear 
inclusion and exclusion criteria, proceedings free of computers with everything paper-based. 
However, even though attempted to foresee all eventualities, I quickly learned that a clinical 
trial requires continuous supervision and regular visits.  
When not on-site, it is important to provide regular support and feedback to the study nurses 
and local researchers by ensuring technical support for data checks and trial oversights, and 
by maintaining a clear and consistent communication, with an emphasis on strict adherence to 
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the study protocol. It is, however, equally necessary to refrain from interfering with clinical 
decisions. I came close a couple of times but managed to stay out of the discussion. The 
treating surgeons must do their job and trust that all their treatment decisions will be 
respected. 
If feasible, education and training will serve the project well. Investments in capacity building 
and knowledge sharing among partners can lead to long-term collaborations. In this, 
international and local NGOs should be considered key actors, but most important are the 
local healthcare workers and researchers. They are the greatest assets for the project and 
should, together with the patients, benefit the most from the research. 
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MAIN FINDINGS AND DISCUSSION 
Population Characteristics 
The patients receiving surgical treatment for acute conflict-related injuries were 
predominantly male (88%) in their twenties and thirties (Papers I and III) (Table 3). Similar 
overrepresentation of young males has previously been reported, both in trauma cases134 and 
civilians in armed conflict settings.135 In our study settings, selection bias could have been 
introduced by males having better access to transportation, as the patients were often brought 
to the hospital without the assistance of an ambulance. We cannot exclude the possibility of 
the presence of civilian combatants, which would also drive the data towards an 
overrepresentation of young males. Another factor contributing to the overrepresentation 
might be cultural differences. It is noticeable that, in many Middle Eastern cities, men are 
outside more commonly than women and might therefore to be considered at a higher risk for 
injury.  
The majority of those killed and injured due to armed conflict can be found in the working-
age population; direct fatalities are predominantly male.136 Men are often the main, and 
sometimes the sole, breadwinners in the family. Morbidity and mortality in this group will 
lead to devastating consequences for households and entire societies already burdened by 
limited resources. In addition, there is an ongoing change in warfare tactics, with conflicts 
being increasingly fought in urban areas, resulting in more civilians placed in the line of fire. 
The median number of surgeries was three (Paper I), indicating the complexity of injury 
among the patients. In contrast, a report from a high-resource setting, patients with extremity 
gunshot injuries had an average of 1.8 surgeries.137 Contrary to previous reports, gunshot was 
the injury mechanism for the majority (61%) of the patients (Paper III). The amputation rate 
(8%) was in line with previous studies (Papers I and III).138,139 Research indicates that the 
rate of amputations remains unchanged over time in resource-limited conflict settings,140 
whereas in high-resource areas the rates are declining.141,142  
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Table 3. Baseline Characteristics and Outcomes for Civilians who Received Surgical 
Treatment for Acute Conflict-related Injuries  
 
Paper I 
(n=457) 
Paper III 
(n=165) 
Age, median (IQR) 24 (19–33) 28 (21–34) 
Male, n (%) 395 (86) 155 (94) 
Infection, n (%) 49 (11) 29 (18) 
Number of surgeries, median (IQR) 3 (1–5) 2 (2–5) 
Amputation, n (%) 48 (11) 2 (1) 
Inpatient mortality, n (%) 37 (8) 1 (1) 
Days in hospital, median (IQR) 26 (11–54) 10 (5–38) 
IQR, interquartile range. 
Wound infection was associated with poor outcomes and high resource 
consumption among patients receiving surgery for conflict-related injuries 
Wound infection was diagnosed in 78/622 patients (12%) (Papers I and III). MDR bacteria 
was detected in 36/49 of the patients (73%) who had positive wound cultures (Paper I). It is 
unknown whether this unexpectedly high rate is due to colonisation during pre-admission or 
due to HAI. The mean time from hospital presentation to detection of MDR bacteria was 16.5 
days (IQR 8–30). The most commonly detected bacteria were Staphylococcus aureus (73% 
MRSA), Pseudomonas (17% MDR), Klebsiella pneumoniae (82% MDR), Enterobacter 
(78% MDR), and Escherichia coli (100% MDR).  
In Paper I, the mean RTSc did not differ between matched patients with and without 
infection, indicating that injury severity was similar in the two groups. Wound infection was 
associated with worse patient outcomes and an increased burden of care. Patients with an 
infection had more surgeries, including amputations compared to those without an infection. 
The mean number of days in hospital was higher for patients with (77 days), compared to 
patients without an infection (35 days), P=.000001. This association has previously been 
found in both military and civilian settings.143,144 
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The main challenges hospital-based physicians encounter in the management of 
civilians with conflict-related wounds were related to protocol adherence 
Physicians interviewed in Paper II described that the main challenge in the management of 
acute conflict-related wounds was adherence to established treatment protocols. We found a 
consensus and adherence to protocols in certain areas. These areas could be considered 
commonly agreed-upon principles of trauma surgery, such as the use of wound debridement 
and the evaluation of the systemic state of the patient before initiating antibiotic treatment. 
However, we identified factors that made it difficult to follow the protocols. The main 
reasons for protocol deviation were i) limitations imposed on the physicians (lack of space 
and materials, and the unfavourable behaviour of patients and caregivers); ii) a lack of 
consensus on hygiene routines; and iii) deliberate deviations (either to ensure a good doctor-
patient relationship or when medical reasons prevented adherence to the established 
protocols). Qualitative studies on physicians’ adherence to clinical guidelines have shown 
that the approaches to the implementation of clinical guidelines vary substantially145 and that 
guidelines are sometimes viewed as a mere influence on clinical decision making.146 Often, 
other factors such as convenience, malpractice concerns, and physician experience overrule 
clinical guidelines.147 The wording of the guidelines and any disparities with reality will 
influence perceived relevance and, consequently, the adherence.146 The perceived simplicity 
and practicality of the guidelines have been shown to positively affect implementation.148 
Antibiotic-resistant organisms causing HAI are a major concern in resource-limited 
settings.149 Considering the high levels of MDR (73% of infected wounds in Paper I), it was 
surprising that participants described how issues related to HAI were not being prioritised. 
When analysed further, these findings found to be linked to a high workload in combination 
with limited resources.150 A previous study found that the main obstacles to antibiotic 
protocol adherence related to issues of workflow, both inherent and unexpected, and to 
conflicts over the responsibility for the administration of antibiotics.151 In a study of the 
factors influencing the prescription of antibiotics, personal experience influenced prescribing 
decisions, while hospital guidelines did so to a lesser degree.152 Previous research also 
indicated that the hospital design influences the adherence to isolation routines,153 and that 
hygiene protocol compliance tends to go down when patient numbers go up.154 
We found that participants had difficulties differentiating between bacterial contamination 
and infection at presentation after injury, and that this affects the certainty of assessments 
regarding HAI levels. This has also been seen in previous studies.70,155 Clinical guidelines are 
considered essential for providing safe, evidence-based healthcare. However, their 
implementation in daily practice is filled with challenges156 and it remains unclear which 
guideline dissemination and implementation strategies to use in different circumstances.157 
  
 50 
NPWT failed to reduce the time to wound closure and the incidence of wound 
infection in patients with acute conflict-related extremity wounds 
Overall, the groups were well-balanced in terms of their baseline characteristics. However, 
the wounds in the NPWT group had a larger median wound area and a higher rate of injury to 
major blood vessels, exposed bone, nerves or tendons, and fracture at the site of the studied 
wound. 
The wound closure rate by day five was 41/83 (49%) among participants treated with NPWT, 
compared to 49/82 (60%) for those who received standard treatment. Hence, NPWT was not 
superior to standard treatment. In fact, the absolute difference was -10 percentage points, 
indicating that NPWT may be a less effective treatment, 95% CI -5–25, P=.212. It should be 
noted that the power calculation was based on a 25% difference in the rate of participants 
reaching the primary endpoint. The mean time to wound closure did not differ between the 
groups, nor did the net clinical benefit, HR 0.90, 95% CI 0.56–1.45.  
NPWT did not result in an increased chance of wound closure, even after adjusting for the 
imbalances in baseline characteristics, HR 1.17, 95% CI 0.82–1.65, P=.385. A review of the 
available wound photographs for the primary endpoint did not change the initial assessments. 
Wound infection was diagnosed in 10/83 participants (12%) in the NPWT group, and 19/82 
participants (23%) in the standard treatment group with an absolute difference of 11 
percentage points, 95% CI -0.5–23, P=.068. This indicates that NPWT may decrease the 
infection rate, but at the cost of a lower wound closure rate. However, wound infection was a 
secondary endpoint not considered in the sample size calculation. 
In recent years, we have seen large non-governmental actors, such as the ICRC and MSF, 
implementing NPWT in the treatment of civilians with injuries sustained in armed conflict. 
This is concerning, as the evidence grade supporting NPWT as an effective means of 
promoting wound healing is low,82 the technique is expensive, and it requires resources that 
are limited in conflict-affected areas. 
RCTs are considered the gold standard in medical research and represent the highest evidence 
grade.158 However, RCTs are costly, time-consuming, and the generalizability of their results 
has been questioned. Traditionally, patients in resource-limited settings have received 
treatments based on evidence generated in another context or based on the best available 
evidence from observational studies. With the development of the pragmatic randomised 
trials design, this has changed. Data derived from pragmatic randomised trials are often 
considered ‘real-world evidence’, a term used increasingly and associated with sources other 
than RCTs. It has been argued that, compared to conventional RCTs, the pragmatic trial is 
more suitable for the support of real-world healthcare decision making.103 
RCTs in surgical care are rare159 though it has been shown that high-quality RCTs can be 
conducted in trauma settings.160-162 In the context of armed conflict, I have only managed to 
identify one RCT.163 In this trial, 76 military combatants, wounded in Afghanistan and treated 
at a military hospital, were randomised to receive either silver dressings or plain gauze 
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dressings, the standard of care. No difference between the treatment groups was found in the 
primary endpoint of wound colonisation.  
Compared to standard treatment, NPWT was associated with higher treatment-
related costs, and is unlikely to be a cost-effective treatment 
For the primary endpoint, wound closure by day five, the cost of NPWT was $1 332 above 
that of standard treatment (Paper IV). In addition, treatment-related costs were higher for the 
NPWT group. Overall, results were robust in a sensitivity analysis. As we found no evidence 
of superiority for NPWT compared to standard treatment of traumatic extremity wounds 
(Paper III) and costs were higher, NPWT is unlikely to be a cost-effective treatment. These 
conclusions are in line with the results from the only previous cost-effectiveness analysis 
from an RCT of NPWT for traumatic open wounds.164 It should be noted that the health 
outcomes used in the health economic evaluation (Paper IV) were derived from Paper III. 
Consequently, the analysis in Paper IV risks being underpowered to detect meaningful 
differences in economic outcomes. 
The significance of the costs related to the dressings and technology greatly differs between 
settings. In a resource-limited setting, the costs of advanced technology are often a substantial 
part, while in high-income settings, these costs are almost negligible in comparison with costs 
linked to staff time, overhead, and capital expenditures. It is therefore essential for the 
calculations to incorporate nursing time, the number of surgeries or dressing changes, and the 
length of hospital stay in addition to outcomes such as wound closure and wound infection 
rates. 
Research in Resource-limited Settings 
Relative to the high burden of disease in resource-limited settings, the number of clinical 
researchers is low.165 One fundamental requirement to initiate a research project and to be 
granted funding is that the research is deemed relevant. Relevance, however, is a relative 
term. To healthcare workers and researchers in a resource-limited setting, it might be obvious 
which questions would be most relevant. However, when research in resource-limited 
settings is performed by an institution from a high-income country, the funders will often 
need to see its relevance for a high-income context. This may generate a dilemma among 
researchers, often resulting in an unfortunate paradox where resources are allocated to 
research on topics that are of minor importance to the people in the areas where the project is 
being conducted.166 
Consequently, researchers from high-income countries risk the temptation to initiate projects 
that hold relevance for their institutions and funders. In addition, an insufficient will or ability 
to engage local researchers and appropriately credit their involvement will lead to data and 
academic prestige being retained by high-income institutions.167,168 These risks may be 
diminished through thorough planning and partnerships with local institutions and 
international and local NGOs. The identification and engagement of local healthcare workers 
and researchers already at the planning stage is of the outmost importance.2 If possible, pose 
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the question, ‘What would be relevant for you to investigate?’. Subsequently, the identified 
areas could be explored by using qualitative methods to generate hypotheses. The quantitative 
methods used to test these hypotheses might need adaptation to the study setting but it is 
essential that this adaptation does not lead to a substantial loss in evidence quality. To 
perform substandard research is both unethical and a waste of resources. 
There is a concern that knowledge generated in one context cannot be transferred to another 
without a risk of distortion and misinterpretation. Additionally, RCTs of health interventions 
generally fail to report the generalizability of their results.169 Preconditions differ between a 
trauma centre in the United Kingdom and an ad hoc hospital close to a Syrian battlefield. At 
the hospital level, there will most likely be differences in terms of resources, experiences, 
patient load, culture, traditions, and patient behaviour. In addition, the microbiota and 
antimicrobial resistance patterns often vary between two settings, as well as the availability of 
prehospital care, access to healthcare, and transport time to definitive treatment. When 
evidence generated in a stable high-income setting is being directly transferred to a different 
environment without validation, it risks being misinterpreted, leading to a misuse of the 
limited resources available and, in the end, doing more harm than good. In the words of R. M. 
Coupland, ‘Inadequate surgery is worse than nothing’.170 
There are, however, examples of knowledge being transferrable between contexts.171 The 
similarities of two seemingly different settings, armed conflict and urban violence in a 
resource-limited setting, have proven able to use the same standardised package of care.172 In 
this case, the armed conflict setting is probably more closely related to resource scarcity, 
compared to a high-income setting, with a higher chance of cross-cultural validity and 
generalizability.173 This approach should, however, be used with care and requires the 
evaluation and validation of methods. 
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METHODOLOGICAL CONSIDERATIONS 
Strengths and Limitations 
In Papers I and III, injured patients were, at times, not able to access the hospital, and, at 
other times, the research team was unable to reach the study site. Consequently, potentially 
eligible patients were missed, leading to a risk of selection bias, and impaired trial oversight. 
Delays in the transportation of severely injured patients, due to long distances, damaged 
infrastructure, checkpoints, and insecurity, might have negatively affected prehospital 
mortality and, as a consequence, generated survival bias.  
Language was a potential barrier. Interviews in Paper II were conducted in English. 
However, English was neither the first language of the interviewer nor of the participants. In 
addition, most patients enrolled in the randomised trial (Papers III and IV) did not speak 
English, which was the language spoken among the expatriates at Ar Ramtha Hospital and 
among the researchers at both study sites. This language barrier might have generated 
information bias due to misclassification. Misclassification bias could also have been 
introduced by the use of a clinical database in Paper I. The hospital’s use of paper files, non-
strict definitions, and the fact that doctors had limited time to report data may have led to the 
misclassification of exposures and outcomes.  
The overall strengths of this thesis include the collaboration with two civilian hospitals, 
international and local NGOs, healthcare workers, and researchers affiliated with academic 
institutions in Jordan and Iraq. This collaboration has been essential in the development of 
relevant research questions, the implementation of the research, and the interpretation of the 
results. The independence from the medical device industry eliminates bias that may 
otherwise be introduced when corporate interests are allowed to influence the design, 
conduct, analysis, and reporting of a trial.174 
Generalizability 
The classical understanding of generalizability, or external validity, is extrapolating results 
from a sample to a wider or unspecified population.175 To form a representative sample of the 
population, participants are ideally selected at random. In reality, the starting point for a study 
is most commonly the sample, not the population. The importance of generalizability is 
acknowledged in the STROBE, SRQR, CONSORT, and CHEERS guidelines. 
As pointed out in the STROBE statement, adequate reporting is a prerequisite for the reader 
to assess a study’s generalizability.97 This includes details on when and where the study took 
place. In addition, readers need information on the study participants, the exposures 
examined, and the outcomes assessed. In Paper I we used a pre-existing database of routine 
clinical data. As previously mentioned (Study Design and Methods), the information of the 
patients’ baseline characteristics exposures and outcome measures was limited. 
Consequently, the generalizability of the study findings can be questioned. In addition, the 
above-mentioned risk of misclassification bias may affect the study’s internal validity and, in 
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turn, limit the external validity. Details on wound microbiota and resistance patterns are 
context-specific and thus, the generalizability of these results is limited to the specific 
geographical area.  
The randomisation process in an RCT balances patient characteristics between treatment 
groups, securing high internal validity. However, the external validity, and thereby 
generalizability, of traditional RCTs has been questioned pertaining to strict inclusion criteria, 
the exclusion of ‘non-ideal’ patients, and a controlled environment.176 Participants of such 
trials are often highly selected and followed more closely than they would be in a real-world 
setting. To overcome the limitations of a traditional RCT, we used a pragmatic trial design in 
Paper III, with broad inclusion criteria and minimal exclusion criteria, aiming for a 
representative study population with minimal selection bias, and thus, yielding results that are 
more relevant for routine care use.177 We obtained power in excess of the calculated 80% due 
to the low number of dropouts and the high enrolment rate among eligible patients (>60%). 
The study population was heterogeneous, which improves generalizability, at the cost of 
statistical power for subgroup analyses.  
Cost-effectiveness analyses based on RCTs usually struggle with external validity.178 
Limitations can be generated by the specific trial setting, the inclusion criteria and endpoints 
chosen or the length of the follow-up. By using a real-world setting and a pragmatic study 
design, the external validity of Paper IV may have been improved. Other strategies used to 
enable the reader to assess a study’s external validity included a sensitivity analysis and 
transparency in reporting. 
Generalizability is a limitation in qualitative research.100 Since data is generated from a select 
population, it is often difficult to generalize the findings outside of the specific context 
studied.179 In qualitative research it is common to instead use the terms ‘trustworthiness’ and 
‘transferability’.122 We acknowledged the interpretations included in Paper II, and aimed for 
comprehensive reporting of the context and research methodology to achieve trustworthiness. 
Findings were presented in detail, with quotations to allow for alternative interpretations 
among the readers. However, the study findings are derived from a small group of 
participants at one single hospital, limiting generalizability. Due to diversity among the 
participants in Paper II, the study findings might be considered transferrable to similar 
conflict-affected hospital settings in the same geographical area. 
The combination of relative stability and proximity to armed conflict renders our study sites 
and populations suitable for research. Jordan and Iraq are middle-income countries. However, 
in armed conflict, the healthcare services of the affected areas are often overburdened and 
thus considered resource-limited.24 As an illustration, at Ar Ramtha we found insufficiencies 
in hospital infrastructure, medication, and supplies (Paper II). In addition, both study 
hospitals were understaffed, and lacked equipment and trained personnel for reconstructive 
surgery.  
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Both Ar Ramtha Hospital and EMC are civilian hospitals but the distinction between civilian 
and combatant is not clear, especially so in internal armed conflicts.180 Asking patients in 
conflict-affected areas for their combatant status is unethical and risk hurting the patient-
doctor relationship. In addition, there are numerous reasons why a patient would not want to 
disclose such information, including fear of retaliation, persecution or being denied access to 
healthcare. Through interviews with local researchers and healthcare personnel, we found that 
the patients included in the studies did not wear helmets or body armour and were not 
supported by military field-hospitals, forward surgical teams or rapid casualty evacuation. 
Although our studies have limitations and biases, we suggest that the results may be valid for  
civilian patients with acute conflict-related extremity wounds treated in other resource-limited 
settings. 
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CONCLUSIONS 
 
Wound infection was associated with poor clinical outcomes and an excess resource 
consumption among patients receiving surgery for conflict-related injuries. In addition, these 
patients had a higher incidence of MDR infection than has previously been shown. 
Wound management is complex, and physicians treating conflict-related wounds found 
protocol adherence to be the main challenge. Reasons for protocol deviations included 
resource scarcity, high patient loads, and limited compliance among patients and caregivers. 
Neither time to wound closure nor net clinical benefit was improved by NPWT compared 
to standard treatment for conflict-related extremity wounds.  
Treatment-related healthcare costs were higher for NPWT compared to standard treatment, 
indicating that NPWT is not a cost-effective treatment option. 
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CLINICAL IMPLICATIONS AND FUTURE PERSPECTIVES 
Hopefully, this thesis will serve as a step towards improving the evidence base for the care of 
civilians with conflict-related injuries in terms of results and the reporting of research 
methods. Keeping in mind the methodological considerations regarding limitations and 
generalizability, as alluded to previously, this section discusses the potential clinical 
implications of this thesis, as well as future research. 
The strong overrepresentation of young males in Papers I and III implies that our study 
populations probably do not represent the full picture. The true epidemiology for civilians 
wounded in a conflict-affected area cannot be understood at the hospital level but needs to be 
studied closer to the population. Most suitable would be a mixed-methods approach, 
including quantitative as well as qualitative data collection and analysis. Potential biases must 
also be considered, such as selection bias by the patients’ limited access to healthcare 
(transportation, security checkpoints) and survival bias, generated by severely injured patients 
who die before they reach the hospital. One strategy towards the inclusion of these patients 
would be to cooperate with the local prehospital services and morgues and incorporate their 
data into the analysis. 
Microbiota and their resistance patterns will vary depending on the setting. Antibiotic 
strategies therefore need to be locally adapted to be effective. In this thesis, I report methods 
used to generate context-specific knowledge on the microbiota in infected conflict-related 
wounds. An advantage with this approach compared to screening is that the results are more 
likely to represent clinically-relevant pathogens and thus, could be more useful as an aid in 
treatment decisions. However, the development and validation of a rapid assessment method 
could prove to be a more feasible means of directly guiding clinicians in their treatment 
strategies. 
We have mapped the challenges physicians experience in the management of conflict-related 
wounds. Hopefully, these results can provide some insights for resource allocation and the 
development of protocols for wound care, hygiene, and antibiotic use in similar settings. 
However, many questions are left unanswered. The factors affecting adherence to protocols 
could be explored in more depth along with why there were split views on the significance of 
HAI and antibiotic resistance development. Focus group discussions could serve as a first 
step towards resolving the identified discrepancies between protocol recommendations and 
actual practice. 
For our primary endpoint, wound closure by day five, NPWT did not prove to be superior to 
standard treatment. In fact, the absolute difference in wound closure rate was 10% in favour 
of standard treatment (P=.212). NPWT had a lower wound infection rate than standard 
treatment; however, these results were not statistically significant (P=.068). It should be noted 
that our power calculation was made for our primary endpoint. A larger trial might find a 
statistically significant difference in wound infection rate. There could even be a link between 
the two, with the risk of infectious complications being limited by decisions not to close 
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wounds prematurely. The hypothesis of NPWT being a better treatment for some patients at 
risk of wound infection, but unsuitable for routine use could be inferred from the results in 
Paper III, although the number of included patients did not allow for further subgroup 
analyses. However, this hypothesis would be realistic to study in a non-pragmatic RCT. 
Through the widespread use of mobile phones, we were able to reach many of our patients 
for follow-up after hospital discharge. However, the displacement of the study populations 
rendered return visits nearly impossible to organise. 
Regarding the health economic evaluation of NPWT, the non-significant differences in 
clinical effect make it difficult to draw any clear conclusions. Paper III was a superiority trial 
which was not designed to detect equivalence in terms of outcomes. If there is, in fact, a true 
equivalence, this would have to be proven in a non-inferiority trial. Subsequently, a cost-
minimisation analysis could be performed. However, the analysis performed based on our 
health outcomes in Paper III shows that NPWT is unlikely to be a cost-effective treatment for 
these patients. 
NPWT may serve purposes not studied in this thesis, such as improving the quality of life for 
injured patients. Neither Paper III nor Paper IV discussed the patients’ experiences, e.g. 
wound-associated pain and health-related quality of life. Consequently, potentially important 
aspects of the treatment methods could have been neglected. However, we have collected 
patient-reported data on psychological distress181 and wound-specific details, e.g. discharge, 
foul smell, movement impairment, pain, discomfort, and sleep quality. Further analyses are 
ongoing to help clarify these issues. 
To perform an RCT in resource-limited settings is challenging. The GCP offers guidance to 
some extent. However, GCP instructions and training are generally directed towards research 
by pharmaceutical companies acting in controlled environments and hence are not always 
applicable to a real-world setting.182 The CONSORT guidelines for pragmatic trials proved to 
be helpful both for planning and conducting the trial, as well as in reporting our findings.103 I 
recommend that research projects in challenging settings make use of these guidelines.  
I have reported the utility of observational and qualitative research methods, as well as the 
pragmatic randomised trial design, to generate evidence in conflict-affected settings. In these 
settings, access to populations over time is a major challenge. Insecurity, insufficient 
infrastructure and human resources, and difficulties allocating resources to research all call 
for the utilisation of a pragmatic adaptation of research methodologies and adjustments to fit 
the local conditions. Visits to the study site and collaboration with local researchers is 
essential in the planning phase. Ideally, a feasibility analysis should be conducted before 
initiating a study. If possible, dedicated local research personnel, e.g. study nurses, should be 
given relevant training, such as GCP. The high turnover rate of expatriate staff made it 
difficult to deeply engage them in the trial proceedings in Ar Ramtha. At both EMC and Ar 
Ramtha Hospital, we involved local healthcare workers in the research and subsequent 
publication of scientific articles. Hopefully, this will assist local capacity development and 
stimulate future research projects.  
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There are many important aspects related to conflict-injury management in resource-limited 
settings not covered in this thesis, including prehospital management and access to 
healthcare, postoperative care, functional outcomes, and rehabilitation. These areas are all in 
need of further investigation.  
Retrospective analyses, as utilised in Paper I, requires sufficient data quality. Prospective 
collection of original data (Paper III) is considerably costlier and more time-consuming. 
However, given an adequate study design and thorough execution, the data collected will be 
of high quality. The publication of the first-ever randomised clinical trial performed in 
resource-limited civilian settings close to armed conflict should call attention to the feasibility 
of the development of high-quality trials to generate level-one evidence in similarly 
challenging settings. Hopefully, this thesis may serve to inspire other researchers and change 
the current paradigm in which limited data is used to justify the scarcity of evidence-based 
treatment protocols for civilians in conflict-affected areas. 
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SAMMANFATTNING PÅ SVENSKA 
Effekterna av väpnade konflikter drabbar civilbefolkningen världen över. Konfliktområden 
har ofta en eftersatt folkhälsa och en begränsad motståndskraft mot den extra börda som en 
väpnad konflikt medför. Dessutom saknas forskning rörande hur konfliktrelaterade skador 
hos civila skall handläggas på bästa sätt. 
Syftet med denna avhandling är att generera ny kunskap om de människor som skadas vid 
väpnade konflikter i resursknappa miljöer, hur sårinfektion påverkar utfall och vilka de 
huvudsakliga utmaningarna är när det gäller behandlingen av dessa skador. Därutöver ville vi 
utvärdera en ny metod, lokal undertrycksbehandling, gällande säkerhet, effektivitet, 
användbarhet, och kostnadseffektivitet vid behandling av konfliktrelaterade extremitetssår. 
Alla patienter i denna avhandling skadades i väpnade konflikter i Syrien och i Irak. Studierna 
utfördes på två civila sjukhus i Jordanien och irakiska Kurdistan. I en kohortstudie 
inkluderade vi alla patienter med akuta konfliktrelaterade skador som genomgått kirurgisk 
behandling vid ett sjukhus i Jordanien. Vi jämförde patienter med sårinfektion mot de utan 
sårinfektion avseende kliniskt utfall och resursåtgång. Vi fann att patienter med infektion 
vårdades längre och behövde fler operationer, inklusive amputationer. Därutöver så fann vi 
att tre av fyra infekterade sår innehöll multiresistenta bakterier. I en kvalitativ studie 
intervjuade vi läkare på sjukhuset i Jordanien. De beskrev att de huvudsakliga utmaningarna i 
behandlingen av konflikt-relaterade skador rörde följsamhet till behandlingsriktlinjer. Dels 
upplevde läkarna att resursbrist försvårade följsamheten, dels var bristen på följsamhet 
relaterad till beteenden hos patienter och anhöriga. I en randomiserad kontrollerad prövning 
jämförde vi lokal undertrycksbehandling med standardbehandling för konfliktrelaterade 
extremitetssår. Vuxna patienter med akuta skador randomiserades i samband med deras första 
operation. Lokal undertrycksbehandling förkortade inte tid till sårförslutning men medförde 
högre kostnader jämfört med standardbehandling. Våra resultat talar således emot att lokal 
undertrycksbehandling skulle vara en effektiv eller kostnadseffektiv behandling för patienter 
med konfliktrelaterade extremitetssår. Dessa patienter bör därför erhålla standardbehandling. 
Den höga frekvensen av multiresistenta bakterier i sår hos patienter med konfliktrelaterade 
skador samt att sårinfektion var associerat med försämrat kliniskt utfall indikerar att riktlinjer 
för sårbehandling bör anpassas till lokala förutsättningar. Resurser krävs för att öka 
följsamheten till dessa riktlinjer. 
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